Share on StockTwits

Bio-Reference Laboratories (NASDAQ:BRLI) issued its quarterly earnings data on Wednesday. The company reported $0.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.02, AnalystRatings.NET reports. During the same quarter in the prior year, the company posted $0.53 earnings per share.

Shares of Bio-Reference Laboratories (NASDAQ:BRLI) opened at 32.08 on Wednesday. Bio-Reference Laboratories has a 1-year low of $24.13 and a 1-year high of $37.97. The stock’s 50-day moving average is $31.36 and its 200-day moving average is $28.41. The company has a market cap of $889.1 million and a price-to-earnings ratio of 22.70.

Bio-Reference Laboratories, Inc (NASDAQ:BRLI) is a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units.

Receive News & Ratings for Bio-Reference Laboratories Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Reference Laboratories Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.